ENDRA Life Sciences (NDRA) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts NDRA Hot Sheet
Join SI Premium – FREE
ENDRA Life Sciences (NASDAQ: NDRA) reported Q2 EPS of ($0.08).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- BofA Securities Upgrades Americold Realty Trust (COLD) to Neutral
- H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
